| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/12/2008 | US7410954 Adenovirus serotype 30 (Ad30) |
| 08/12/2008 | US7410953 Anticancer agent |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410798 Culturing preferential cells; generate nutrient broth, inoculate with cells, propagate cells, recover cells |
| 08/12/2008 | US7410797 Preparing populations of progenitor cells that differentiate into a preselected cell type with high efficiency |
| 08/12/2008 | US7410795 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 08/12/2008 | US7410791 Plate with regions formed of self-assembled monolayer where binding occurs in single-line; transparent to electromagnetic radiation |
| 08/12/2008 | US7410787 Diagnosis of Whipple's disease |
| 08/12/2008 | US7410780 IL-21 antagonists |
| 08/12/2008 | US7410778 Expression vector comprising nucleotide sequences coding membrane receptor for use in identifying modulator for prevention and treatment of metabolic disorders; hormone replacement therapy |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/12/2008 | US7410776 Novel ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; use treating HIV infection, cancer, and various other diseases and disorders |
| 08/12/2008 | US7410774 Compounds modulating sister chromatid separation and method for identifying same |
| 08/12/2008 | US7410773 Method of preparing an undifferentiated cell |
| 08/12/2008 | US7410767 Contacting natural killer cells expressing CD94 receptor with human leukocyte antigen (HLA) and test compound; |
| 08/12/2008 | US7410648 Nucleotide sequences coding outer memebrane proteins for use as tools in diagnosis, prevention and treatment of microorganismal infection; immunotherapy; vaccine development |
| 08/12/2008 | US7410647 Vaccines |
| 08/12/2008 | US7410645 Moraxella (Branhamella) catarrhalis antigens |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 08/12/2008 | US7410637 Transgenic algae for delivering antigens to an animal |
| 08/12/2008 | CA2354845C Expression system for factor viii |
| 08/12/2008 | CA2320224C Method for modulating macrophage activation |
| 08/12/2008 | CA2302534C Organic cation transporter genes |
| 08/12/2008 | CA2256357C Enhanced production of taxanes by cell cultures of taxus species |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |
| 08/12/2008 | CA2131190C Compositions and methods for the treatment of thermal injury |
| 08/07/2008 | WO2008095141A2 Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease |
| 08/07/2008 | WO2008094597A2 Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc) |
| 08/07/2008 | WO2008093886A1 Mcf7-derived cell |
| 08/07/2008 | WO2008093688A1 CHIMERIC Fcγ RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 08/07/2008 | WO2008093646A1 Peptide capable of activating wnt signaling |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008093280A2 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 08/07/2008 | WO2008093225A2 Sub -population of hematopoietic stem cells that express the crisp-1 protein |
| 08/07/2008 | WO2008092445A2 Method for modulating the immune response by activating or inactivating the notch and/or stat4 signal path |
| 08/07/2008 | WO2008092440A2 Therapeutic composition, and use of a cell-free substance |
| 08/07/2008 | WO2008076960A3 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 08/07/2008 | WO2008076960A2 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 08/07/2008 | WO2008067422A3 Replication of undifferentiated diploid cells in a weightless environment, uses thereof and a facility for such replication |
| 08/07/2008 | WO2008063837A9 Dendritic cell tumor injection therapy and related vaccine |
| 08/07/2008 | WO2008058216A3 Enriched stem cell and progenitor cell populations, and methods of producing and using such populations |
| 08/07/2008 | WO2008055224A3 Lithium stimulation of cord blood stem cell proliferation and growth factor production |
| 08/07/2008 | WO2008054421A3 Frozen cell and tissue microarrays |
| 08/07/2008 | WO2008019148A3 Tumor suppression using placental stem cells |
| 08/07/2008 | WO2008016380A3 Installation of genomes or partial genomes into cells or cell-like systems |
| 08/07/2008 | WO2007149000A3 New structural protein preparations |
| 08/07/2008 | WO2007131232A3 Compositions and their uses directed to ptpr alpha |
| 08/07/2008 | WO2007121359A3 Biogenerator constructed using live cell cultures |
| 08/07/2008 | WO2007047955A3 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 08/07/2008 | US20080189808 Inbred Corn Line CC1 |
| 08/07/2008 | US20080189807 Nitrogen Transport Metabolism |
| 08/07/2008 | US20080189806 Protein kinase stress-related proteins and methods of use in plants |
| 08/07/2008 | US20080189805 Novel genes and rna molecules that confer stress tolerance |
| 08/07/2008 | US20080189804 Novel genes and rna molecules that confer stress tolerance |
| 08/07/2008 | US20080189803 Expression cassette comprising protein expressed by heterologous DNA sequence; monocotyledons and dicotyledons with herbicide resistance |
| 08/07/2008 | US20080189800 Certain human genomic DNA associated with total red-green colorblindness |
| 08/07/2008 | US20080188457 Modulation of Neurogenesis with Biguanides and GSK3-beta Agents |
| 08/07/2008 | US20080188450 Macrolactams by engineered biosynthesis |
| 08/07/2008 | US20080188449 Treatment of Conditions Caused By Calcium Abnormalities |
| 08/07/2008 | US20080188447 Glucocorticoid-lowering composition |
| 08/07/2008 | US20080188436 Intact Minicells as Vectors for DNA Transfer and Gene Therapy In Vitro and In Vivo |
| 08/07/2008 | US20080188434 Providing a DNA sample, detecting the amplification of a nucleic acid sequence in chromosomal region 8p22, amplification indicates that the patient has, or is susceptible of developing cancer; inhibition of FGF-20 activity inhibits the growth of cancer cells |
| 08/07/2008 | US20080188429 Synthetic siRNA compounds and methods for the downregulation of gene expression |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188412 Anticancer agent screening; contacting in vitro with BH4 domain peptide and/or mimetic to inhibit union with FK-binding protein 38; overcoming drug resistant strains |
| 08/07/2008 | US20080188406 Methods and reagents for treating glucose metabolic disorders |
| 08/07/2008 | US20080188401 Compounds |
| 08/07/2008 | US20080188379 Ptu compounds for promoting the in vitro culture of (highly pigmented) melanocytes |
| 08/07/2008 | US20080187998 For use as endosomolytic reagents for transfection with polymeric or lipid-based vectors; in vitro transfection; liposomes; plasmids |
| 08/07/2008 | US20080187996 Nanofibers, nanofilms and methods of making/using thereof |
| 08/07/2008 | US20080187995 Using solid support comprising nanotextured grooves as bioreactor for propagation of preferential cells |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187992 Contacting a tumor cell, cancer cell or transformed cell expressing a Stat3 transcription factor with the platinum complex to inhibit a Stat3 transcription factor |
| 08/07/2008 | US20080187991 Process For Sorting Motile Particles From Lesser-Motile Particles And Apparatus Suitable Therefor |
| 08/07/2008 | US20080187984 Transgenic cell for use as bioreactor in production of ascorbic acid |
| 08/07/2008 | US20080187970 Beta-Fructofuranosidase Variants |
| 08/07/2008 | US20080187962 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187959 Sulfotransferase, peptide thereof and dna encoding the same |
| 08/07/2008 | US20080187958 Subtilases |
| 08/07/2008 | US20080187953 Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
| 08/07/2008 | US20080187950 Identification and isolation of acute myeloid leukemia stem cells |
| 08/07/2008 | US20080187942 Methods of using chimeric receptors to identify autoimmune disease |
| 08/07/2008 | US20080187938 Using alcohol dehydrogenase expression as diagnostic indicator of solid tumor stem cells |
| 08/07/2008 | US20080187933 Viral DNA fragments for use as probes in detecting viral infection |
| 08/07/2008 | US20080187917 Using antisense agents to control expression from ADP ribosylation factor gene and tumor supressor gene sequences and treat nervous system disorders |
| 08/07/2008 | US20080187646 Increase in Yield by Reducing Gene Expression |
| 08/07/2008 | US20080187604 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 08/07/2008 | US20080187577 Immunogenic compositions comprising progastrin and uses thereof |
| 08/07/2008 | US20080187559 Solvent extraction of lipids from cancer cells; mixture of cancer cell particles and carrier that induce immunology stimulation |
| 08/07/2008 | US20080187557 Vaccine Against Pandemic Strains Of Influenza Viruses |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy |
| 08/07/2008 | US20080187534 Anti-vegf antibodies |
| 08/07/2008 | US20080187532 Compositions and methods for diagnosing and treating cancer |